Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081922 | Drug Discovery Today: Disease Mechanisms | 2006 | 7 Pages |
Abstract
Liver fibrosis, the formation of a hepatic scar in chronic liver injury, results from complex interrelated changes in the extracellular matrix, cell populations and cytokines of the liver. Although myofibroblasts derived from hepatic stellate cells are important collagen-producing cells, recent research has identified additional fibrogenic cell populations as well as new soluble, mechanical and immunologic mediators of fibrosis. These findings have greatly expanded the range of possible targets for antifibrotic therapy.
Section editor:Yu-Xiao Yang – University of Pennsylvania, Philadelphia, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Rebecca G. Wells,